Correlation Between Metacrine and Nuvation Bio
Can any of the company-specific risk be diversified away by investing in both Metacrine and Nuvation Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Metacrine and Nuvation Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Metacrine and Nuvation Bio, you can compare the effects of market volatilities on Metacrine and Nuvation Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Metacrine with a short position of Nuvation Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Metacrine and Nuvation Bio.
Diversification Opportunities for Metacrine and Nuvation Bio
0.28 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Metacrine and Nuvation is 0.28. Overlapping area represents the amount of risk that can be diversified away by holding Metacrine and Nuvation Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nuvation Bio and Metacrine is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Metacrine are associated (or correlated) with Nuvation Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nuvation Bio has no effect on the direction of Metacrine i.e., Metacrine and Nuvation Bio go up and down completely randomly.
Pair Corralation between Metacrine and Nuvation Bio
If you would invest 162.00 in Nuvation Bio on August 29, 2024 and sell it today you would earn a total of 127.00 from holding Nuvation Bio or generate 78.4% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 0.25% |
| Values | Daily Returns |
Metacrine vs. Nuvation Bio
Performance |
| Timeline |
| Metacrine |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Nuvation Bio |
Metacrine and Nuvation Bio Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Metacrine and Nuvation Bio
The main advantage of trading using opposite Metacrine and Nuvation Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Metacrine position performs unexpectedly, Nuvation Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nuvation Bio will offset losses from the drop in Nuvation Bio's long position.| Metacrine vs. Protara Therapeutics | Metacrine vs. CytomX Therapeutics | Metacrine vs. Assembly Biosciences | Metacrine vs. Instil Bio |
| Nuvation Bio vs. Eliem Therapeutics | Nuvation Bio vs. Scpharmaceuticals | Nuvation Bio vs. Milestone Pharmaceuticals | Nuvation Bio vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Complementary Tools
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |